HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Caccamo, N. Articles by Salerno, A. Search for Related Content PubMed PubMed Citation Articles by Caccamo, N. Articles by Salerno, A.

CXCR5 Identifies a Subset of V9V2 T Cells which Secrete IL-4 and IL-10 and Help B Cells for Antibody Production¹

Nadia Caccamo^*, Luca Battistini, Marc Bonneville, Fabrizio Poccia, Jean Jacques Fournié^¶, Serena Meraviglia^*, Giovanna Borsellino, Richard A. Kroczek^||, Carmela La Mendola^*, Emmanuel Scotet, Francesco Dieli^2,* and Alfredo Salerno^*

^* Dipartimento di Biopatologia e Metodologie Biomediche, Università di Palermo, Palermo, Italy; Neuroimmunology Unit, Istituto di Ricovero e Cura a Carattere Scientifico Santa Lucia Foundation, Rome, Italy; Institut National de la Santé et de la Recherche Médicale (Inserm) Unité 601, Institut de Biologie, Nantes, France; Laboratory of Immunology, National Institute for Infectious Diseases "L. Spallanzani," Rome, Italy; ^¶ Inserm, Unité 563, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France; and ^|| Molecular Immunology, Robert Koch Institute, Berlin, Germany

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
V9V2 T lymphocytes recognize nonpeptidic Ags and mount effector functions in cellular immune responses against microorganisms and tumors, but little is known about their role in Ab-mediated immune responses. We show here that expression of CXCR5 identifies a unique subset of V9V2 T cells which express the costimulatory molecules ICOS and CD40L, secrete IL-2, IL-4, and IL-10 and help B cells for Ab production. These properties portray CXCR5⁺V9V2 T cells as a distinct memory T cell subset with B cell helper function.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
Aminor T cell population, T cells have a unique pattern of Ag recognition. In humans, the vast majority of circulating T cells express a TCR comprised of V9 and V2 chains which directly recognize nonpeptide ligands without presentation by MHC molecules (1). The nonpeptide ligands, referred to as phosphoantigens, comprise isoprenoid pathway metabolites derived from mycobacteria (2, 3, 4, 5) and tumor cells (6). Accordingly, pharmacological agents promoting accumulation of such metabolites, such as aminobisphosphonates (7), sensitize cells to V9V2 T cell recognition. Moreover, it has been recently found that ATPase expressed on tumor cell surface promotes tumor recognition by V9V2 T cells (8).

V9V2 T lymphocytes are heterogeneous and comprise distinct populations that can be distinguished on the basis of surface markers expression, effector functions, and migratory properties: naive (CD45RA⁺CD27⁺) and central memory (T_CM³; CD45RA^–CD27⁺) cells home to secondary lymphoid organs and lack immediate effector functions, while effector memory (T_EM; CD45RA^–CD27^–) and terminally differentiated (CD45RA⁺CD27^–) cells home to sites of inflammation where they display immediate effector functions such as cytokine production and cytotoxicity, respectively (9). Based on their effector properties, V9V2 T lymphocytes are supposed to play an important role in cellular immune responses against intracellular microorganisms and tumors (10). However, whether V9V2 T lymphocytes also participate in Ab-mediated immune responses remains unclear. Earlier pioneering studies in T cell-deficient mice demonstrated a nonredundant role for T cells in the generation of antimicrobial Abs (11, 12) and autoantibodies (13, 14, 15), but as T cell-deficient mice did not show marked defects in IgM and IgG production, T cells may have a modulatory, rather than a primary function in the control of humoral immunity. Ab production was also increased in in vitro cultures of human T cells with B cells (16, 17), but the amount of secreted Ab was low and the mechanisms underlying the observed B cell help were not examined. A more recent study (18) has shown that human T cells are found in the follicles of secondary lymphoid organs, express costimulatory molecules after TCR triggering, and provide B cell help in vitro, but the intrafollicular T cell subset responsible for such an activity was not identified.

We show here that expression of CXCR5 defines a subset of peripheral blood V9V2 cells which upon Ag stimulation express the costimulatory molecules ICOS and CD40L, secrete IL-4 and IL-10, and provide B cell help for Ab production in vitro.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
Subjects

PBMC were obtained from the heparinized blood of 15 healthy volunteers (9 males, 6 females, age range 20–23 years). PBMC and tonsils were obtained from seven individuals undergoing tonsillectomy (four males, three females, age range 9–14 years). All individuals gave informed consent to participate to this study.

FACS staining and sorting

PBMC were isolated from heparinized blood or tonsils by Ficoll-Hypaque (Pharmacia Biotech). The following conjugated Abs were used in different combinations: anti-V2 (Coulter), anti-V9 (Coulter), anti-CD27 (BD Pharmingen), anti-CD45RA (Coulter), anti-CD45RO (Coulter), anti-CD3 (Sigma-Aldrich), anti-CD25 (BD Pharmingen), anti-CD62L (BD Pharmingen), anti-CCR7 (a gift of Dr. M. Lipp, Max-Delbruch-Center for Molecular Medicine, Berlin, Germany), anti-HLA DR monomorphic (a gift of Prof. V. Horejsi, Institute of Molecular Genetics, Academy of Science of the Czech Republic, Prague, Czech Republic), anti-CCR5 (BD Pharmingen), anti-CXCR3 (BD Pharmingen), anti-ICOS, anti-CD40L (BD Pharmingen), and anti-CXCR5 (R&D Systems). Data were acquired on a FACSCalibur or a FACSCanto instruments (BD Biosciences) and analyzed using CellQuest software (BD Immunocytometry Systems) or FlowJo (Tree Star). Tonsillar B cells were isolated by use of CD19 microbeads (Miltenyi Biotec), according to the manufacturer’s instruction. For isolation of peripheral blood naive B cells, the procedure described in Ref. 19 was used. Briefly, CD19⁺ cells were first isolated by the use of CD19 microbeads and were labeled with 25 nM MitoTracker Green FM (Molecular Probes), a substrate for ABCB1, for 25 min at 37° C and washed twice. Following staining for CD27 and surface IgG, naive B cells (CD19⁺CD27^–IgG^– ABCB1⁺) were sorted by FACSVantage (BD Biosciences) with a purity of 99%. Different subsets of V9V2 T cells were sorted similarly by FACSVantage (BD Biosciences).

Cytokine production and chemotaxis assay

The medium used throughout was complete RPMI 1640 medium (Invitrogen Life Technologies) supplemented with 10% heat-inactivated FCS (Invitrogen Life Technologies), 2 mM L-glutamine, 20 nM HEPES and 100 U/ml penicillin/streptomycin. Sorted V2 cell subsets were cultured at 37°C, in the presence of 5% CO₂, at 10⁵/ml in 96-well flat-bottom plates (0.2 ml/well), with different concentrations of bromohydrinpyrophosphate (BrHPP) in the presence of irradiated (5000 rad from a cesium source) allogeneic dendritic cells (20). IFN-, TNF-, IL-2, IL-4, and IL-10 levels in the 24-h culture supernatants were assessed by two mAbs sandwich ELISA following manufacturer’s recommendations (R&D Systems).

The chemotactic ability of CXCR5⁺V9V2 cells was assayed using a double-chamber system with 3-µm pores (Transwell; Costar), according to Ref. 21 . Briefly, 10⁵ sorted CXCR5⁺ or CXCR5^– V9V2 cells were added to the upper chamber and CXCL13 (recombinant human CXCL13, BCA-1; R&D Systems, 3 µM final concentration) to the lower chamber and incubated at 37°C for 2 h in a 5% CO₂ humidified incubator. In some experiments, anti-CXCR5 or isotype control mAbs were added to the lower chamber during the test. Assays were performed in triplicate. Afterward, the membrane was removed, washed on the upper side with PBS, fixed, and stained. Migrated cells were counted microscopically at x1000 magnification in five randomly selected fields per well. Percentage migration was calculated by measuring the counts recovered from the lower chamber and comparing them to the total input counts; results represent the mean ± SD of three independent experiments.

Ab production in vitro

V9V2 T cell help in Ab production was studied as follows. Different subsets of peripheral blood V9V2 T cells were sorted by FACS and cocultured with sorted tonsillar B cells or peripheral blood-derived naive B cells, in 96-well plates at 10⁵ cells/well each of T and B cells in the presence or absence of BrHPP for 10 days. IgM, IgG, and IgA levels in the culture supernatants were determined by ELISA. When naive B cells were used, F(ab')₂ of goat anti-human Ig (Jackson ImmunoResearch Laboratories) was added to cultures as a BCR trigger, at the final concentration of 2 µg/ml. Anti-CD40L mAb and ICOS ligand fused to the Fc portion of mouse IgG2a (ICOSL-muIg; both reagents from Alexis through Vinci-Biochem, Firenze, Italy), neutralizing anti-human IL-4 and IL-10 (BD Biosciences) and isotype matched control mAbs, were added at the beginning of cultures at the final concentration of 15 µg/ml. As a control of the ICOSL-muIg, we used mouse IL-7 fused to the Fc portion of mouse IgG2a (a gift from Prof. G. Stassi, Department of Surgical and Oncological Science, University of Palermo, Palermo, Italy).

Statistics

The double-tailed Student t test was used to analyze the significance of differences between groups.

	Results

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
Expression of CXCR5 on human V9V2 T cells

Expression of the chemokine receptor CXCR5 defines a population of CD4 Th cells which support the production of Igs (21, 22). CXCR5 expression has been also detected on human V9V2 T cells by some authors (23), but not by others (18).

CXCR5 expression was studied on peripheral blood V9V2 T cells. In a population of healthy donors (n = 15, age range 20–23 years), 15% of total V2 T cells are CXCR5⁺ (14.6 ± 6.2, range 5.3–46.8, see Fig. 1). In a cohort of seven young patients (age range 9–14 years) undergoing tonsillectomy the percentage of peripheral blood CXCR5⁺V2 T cells was not significantly different from in adults (15.8 ± 7.3, range 4.8–39.5, data not shown). However, CXCR5⁺V9V2 T cells were highly enriched in inflamed tonsils where they account for about half the size of the V9V2 T cell population (Fig. 1).

View larger version (9K): [in this window] [in a new window]   FIGURE 1. Distribution and phenotype of CXCR5+V9V2 T cells in peripheral blood and tonsils. a, Analysis of the relative proportion of CXCR5+V9V2 T cells in peripheral blood and tonsils. b, FACS analysis of peripheral blood and tonsils mononuclear cells stained with different Abs.

View this table: [in this window] [in a new window]   Table I. Surface markers expression on CXCR5+V9V2+ T cells in peripheral blood and inflamed tonsilsa

To assess whether costimulatory molecules expression of tonsil CXCR5⁺V9V2 T cells was due to Ag-dependent activation, we sorted CXCR5⁺ and CXCR5^– V9V2 T_CM and V9V2 T_EM cells from peripheral blood and cultured in vitro with BrHPP and irradiated dendritic cells. None of the three subsets stained positive for ICOS and CD40L either in the absence or 24 h after Ag stimulation in vitro (data not shown). However, after 48 and 72 h of Ag stimulation, CXCR5⁺ and, although at a lower extent CXCR5^– V9V2 T_CM and V9V2 T_EM cells expressed CD40L, while ICOS expression was detected only on CXCR5⁺ V9V2 T_CM cells (Fig. 2).

View larger version (20K): [in this window] [in a new window]   FIGURE 2. Activation-dependent expression of costimulatory molecules in CXCR5+ and CXCR5–V9V2 T cell subsets. FACS analysis of CD40L and ICOS expression on different subsets of peripheral blood V9V2 T cells before (black line) or 48 h (blue line) and 72 h (green line) after stimulation with BrHPP. Control mAb stainings are shown in red filled histograms.

Migratory properties and cytokine production of CXCR5⁺V9V2 T cells

Freshly isolated tonsillar CXCR5⁺, but not CXCR5^–, V9V2 T cells migrated readily in response to CXCL13/BCA-1 (Fig. 3a). Responsiveness to BCA-1 was enhanced when the cells were cultured in vitro with BrHPP, but by day 3 of culture migration in response to BCA-1 consistently decreased; this effect was paralleled by CXCR5 receptor expression, which uniformly decreased upon in vitro culture with BrHPP (Fig. 3a). Of note, migration of tonsillar CXCR5⁺V9V2 T cells in response to CXCL13/BCA-1 was consistently inhibited by anti-CXCR5 mAb (Fig. 3b).

View larger version (10K): [in this window] [in a new window]   FIGURE 3. Migration to CXCL13/BCA-1 and CXCR5 expression during culture of tonsillar CXCR5+V9V2 T cells. In a, freshly isolated tonsillar CXCR5+ () or CXCR5– () V9V2 T cells were cultured with BrHPP for up to 8 days and examined for in vitro migration to CXCL13/BCA-1 (3 µM, final concentration) and CXCR5 expression (). In b, migration of tonsillar CXCR5+V9V2 T cells to CXCL13/BCA-1 was conducted in the presence of anti-CXCR5 or isotype-matched control mAbs (15 µg/ml, final concentration). Data are representative of three independent experiments. *, p < 0.05 when compared with groups consisting of CXCR5+V9V2 T migrating to CXCL13 in the absence of any Ab or in the presence of isotype-matched control mAb.

View this table: [in this window] [in a new window]   Table II. Cytokine production by CXCR5+ and CXCR5–V9V2 T cellsa

CXCR5⁺V9V2 T cells help B cells for Ab production

As CXCR5⁺V9V2 T cells express costimulatory molecules, produce IL-4 and IL-10, we tested whether or not these cells were able to support B cells to secrete Igs. Peripheral blood CXCR5⁺ and CXCR5^– V9V2 T cells were further sorted into CD27⁺ and CD27^– populations and the four T cell subsets were cultured with CD19⁺ B cells isolated from the tonsil of the same donor, in the presence or absence of BrHPP. Fig. 4 shows one typical experiment of five. B cells produced comparable very low amounts of IgA, IgG and IgM when cultured for 10 days without V9V2 T cells or with the CXCR5^– fractions (i.e., CXCR5^–CD27⁺V9V2 T_CM and CXCR5^–CD27^–V9V2 T_EM cells). Similarly, very low IgA, IgG, and IgM levels were detected in cocultures of B cells and CXCR5⁺CD27^–V9V2 T cells. In contrast, coculture of B cells with CXCR5⁺CD27⁺ V9V2 T cells and BrHPP resulted in an 18-fold increase in the production of IgG, 8-fold increase in the production of IgA and 7-fold increase in the production of IgM.

View larger version (8K): [in this window] [in a new window]   FIGURE 4. CXCR5+ V9V2 T cells help tonsillar B cells for Ab production. Tonsillar B cells were cultured alone or in the presence of equal numbers of the CXCR5+CD27+, CXCR5+CD27–, CXCR5–CD27+, and CXCR5–CD27– subsets of V9V2 T lymphocytes, in the presence of BrHPP. Ten days later, total IgG, IgA, and IgM levels in culture supernatants were assessed by ELISA. One of five different experiments is shown. *, p < 0.001 when compared with the group consisting of B cell cultured with medium.

View larger version (10K): [in this window] [in a new window]   FIGURE 5. Ag requirement for CXCR5+ V9V2 T cell help. Tonsillar B cells were cultured alone (Nil) or with peripheral blood- or tonsillar-derived total V9V2 T lymphocytes or their CXCR5+ subset, in the presence or absence of BrHPP. Ten days later, total IgG and IgA levels in culture supernatants were assessed by ELISA. One of three different experiments is shown. *, p < 0.001 and **, p < 0.01 when compared with the group consisting of B cell cultured with medium (Nil).

View larger version (9K): [in this window] [in a new window]   FIGURE 6. CXCR5+ V9V2 T-B cell cooperation requires both costimulatory molecules and cytokines. Cocultures of tonsillar B cells and peripheral blood CXCR5+V9V2 T lymphocytes were conducted as described in the legend to Fig. 4, but in the presence of mAbs to costimulatory molecules or cytokines (see Materials and Methods). *, p < 0.005 and **, p < 0.001 when compared with the group consisting of B cells cultured with CXCR5+V9V2 T lymphocytes and BrHPP.

As shown in Fig. 7 (one typical experiment of three), CXCR5⁺V9V2 T cells provided help to naive B cells to produce IgM, IgG, and IgA Abs, thus indicating that this T cell subset is also able to provide help.

View larger version (7K): [in this window] [in a new window]   FIGURE 7. CXCR5+ V9V2 T help naive B cells for Ab production. Naive B cells were sorted from the peripheral blood as indicated in Materials and Methods, and were cultured alone or with peripheral blood CXCR5+ V9V2 T lymphocytes, in the presence of BrHPP and F(ab')2 of goat anti-human Ig as a BCR trigger (2 µg/ml final concentration). Ten days later, total IgG, IgA, and IgM levels in culture supernatants were assessed by ELISA. One of three different experiments is shown. *, p < 0.001 when compared with all other groups.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

Circulating CXCR5⁺V9V2 T cells uniformly coexpress CD45R0, CCR7, and CD62L, but do not express either activation (CD25 and HLA-DR) or costimulatory (CD40L and ICOS) molecules. This subset was heterogeneous in terms of CD27 expression, with the majority (70%) being CD27⁺. Thus, peripheral CXCR5⁺V9V2 T cells likely represent a subpopulation of T_CM cells and, thus, differ from effector memory V9V2 T cells, which are proposed to directly participate in immune responses at inflammatory sites (9). Accordingly, circulating CXCR5⁺ V9V2 T cells lack chemokine receptors, such as CCR5 and CXCR3, that are typically involved in recruitment of effector memory T cells to inflammatory sites in peripheral tissues. This chemokine receptor profile suggests that CXCR5⁺V9V2 T cells home preferentially into secondary lymphoid tissues and, therefore, CXCR5⁺V9V2 T cells from tonsils were selected for further studies.

Practically 50% V9V2 T cells in tonsils are CXCR5⁺ and the majority express activation markers (CD69 and HLA-DR) and costimulatory molecules (CD40L and ICOS) suggesting their engagement in B cell activation. Drastic reduction in cell surface CCR7 and CD62L expression indicates that the majority of local CXCR5⁺V9V2 T cells have recently entered the tonsils.

Tonsillar CXCR5⁺V9V2 T cells readily migrate in response to CXCL13/BCA-1, and the response was consistently inhibited by anti-CXCR5 mAb demonstrating that CXCR5 is functional.

However, both CXCR5 expression and responsiveness to CXCL13/BCA-1 are sensitive to V9V2 T cell activation: in fact, they increased upon phosphoantigen activation, but by day 3 they consistently decrease. The requirements for induction of CXCR5 expression in V9V2 T cells are not defined. Preliminary data indicate that phosphoantigen stimulation in the presence or absence of IL-2 are not sufficient. In mice, CXCR5 expression during primary responses was shown to depend on sequential signaling by CD28 and OX40, suggesting the requirement for APCs (25, 26).

Expression of CXCR5 on human V9V2 T cells is a matter of debate. While Kabelitz and coworkers (23) found this receptor being expressed by a subset of V9V2 T cells, Moser and colleagues (18) did not detect CXCR5 expression on both peripheral blood and tonsillar V9V2 T cells. Moreover, Forster et al. (27) found that in healthy individuals, 2% of peripheral blood T cells, but 23% of tonsillar T cells express BLR1 (presumably CXCR5) and this percentage consistently increased in HIV-infected individuals. We have no obvious explanation for the discrepancy in CXCR5 expression on peripheral blood T cells between these studies but the results report here clearly demonstrate CXCR5 expression by a subset of human V9V2 T cells.

CXCR5 defines a subset of CD4 memory Th cells which are now termed follicular B Th (Th_F) cells (28). Peripheral blood Th_F cells belong to the subset of T_CM cells, i.e., they are resting, CCR7⁺ and nonpolarized (do not produce Th1/Th2-type cytokines upon stimulation). Tonsillar Th_F cells are also nonpolarized but differ from peripheral blood Th_F cells in that they express a range of activation markers and costimulatory molecules.

Th_F cells are highly efficient at providing B cell help and, thus, are expected to be well-equipped with costimulatory molecules and cytokines. In this regard, a significant fraction of tonsillar Th_F cells express CD40L and the majority also express ICOS. However, the cytokine secretion capacity of tonsillar Th_F cells is very limited and only a subpopulation of germinal center-localized Th_F cells has indeed been identified which produces IL-10.

Differently than CXCR5⁺CD4⁺⁺ memory T cells, that are poor producers of cytokines (21, 22), CXCR5⁺V9V2 T cells have a Th2-type pattern of cytokine production upon Ag stimulation in vitro, as they secrete IL-2, IL-4, and IL-10. This contrasts, with the cytokine production pattern of the CXCR5^– T_EM subsets of V9V2 T cells, which preferentially secrete IFN- and TNF-. Moreover, secretion of IL-4 and IL-10 seems confined to the CD27⁺CXCR5⁺ subset of V9V2 T cells. The finding of a population of V9V2 T cells that secretes IL-4 and IL-10 is not new, and expands previous results demonstrating IL-4 production by resting (29, 30, 31) and V9V2 T cell clones (32, 33), most of which express CD27 (M. Bonneville and E. Scotet, unpublished observations).

Production of Th2-type cytokines together with expression of CD40L and ICOS strongly suggests that tonsillar CXCR5⁺V9V2 T cells are engaged in B cell activation and help for Ab production. Interestingly, and differently than CD4⁺ follicular T cells, CD40L, and ICOS are induced late during activation and persist longer, a finding that may be important for their function within germinal centers. In fact, ICOS induces production of various cytokines from recently activated T cells and critically participates in T cell-dependent immune responses (34) and CD40-CD40L interaction is an essential step during a T cell-dependent B cell response as it regulates proliferation of B cells, Ig class switching, and Ab production (35). Consequently, when coculturing sorted tonsillar B cells with various subsets of V9V2 T cells, we observed Ig production only within the CXCR5⁺CD27⁺ fraction, thus identifying this cell population as the classical helper cells. Moreover, Ig production was consistently inhibited by blocking CD40-CD40L and ICOS-ICOSL interactions, or by neutralization of IL-4 or IL-10. Due to the preactivation status of tonsillar B cells and that exogenous stimuli were not required for B cell help by tonsillar V9V2 T cells, one may argue that CXCR5⁺V9V2 T cells may only be active on already activated B cells and hence during secondary Ab responses. However, the finding that circulating CXCR5⁺V9V2 T cells are also able to help circulating naive B cells for Ab production, strongly suggests that they play an important regulatory role in all aspects of humoral immunity.

Contribution of CXCR5⁺V9V2 T cells to Ab-mediated immune responses may occur early during microbial infections, before full development of acquired responses mediated by CD4 T cells, which depends on a series of time-consuming steps, including Ag uptake and processing by tissue DCs, their relocation to draining lymph nodes, and T cell priming and effector cell development. Accordingly, V9V2 T cells induce maturation of myeloid dendritic cells (33, 36, 37, 38) and, even if for a short period of time upon Ag activation, may function as APCs themselves (39, 40).

Thus, V9V2 T cells may influence the subsequent adaptive immune responses through interaction with peripheral dendritic cells and B cells in reactive secondary lymphoid tissues.

	Acknowledgments

 
We thank Dr. M. Lipp, Prof. V. Horejsi, and Prof. G. Stassi for providing us with reagents.

	Disclosures

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 
The authors have no financial conflict of interest.

	Footnotes

 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ This work was supported by grants from the Commission of the European Union, 6FP, contract LSHP-CT-2003-503367, TB-VAC. F.D. was supported by grants from the University of Palermo.

² Address correspondence and reprint requests to Dr. Francesco Dieli, Dipartimento di Biopatologia e Metodologie Biomediche, Università di Palermo, Corso Tukory 211, Palermo 90134 Italy. E-mail address: dieli{at}unipa.it

³ Abbreviations used in this paper: T_CM, central memory T; T_EM, effector memory T; BrHPP, bromohydrinpyrophosphate; Th_F, follicular B Th cell.

Received for publication May 9, 2006. Accepted for publication July 28, 2006.

	References

Top Abstract Introduction Materials and Methods Results Discussion Disclosures References

 

1. Morita, C. T., R. Mariuzza, M. B. Brenner. 2000. Antigen recognition by human T cells: pattern recognition by the adaptive immune system. Springer Semin. Immunopathol. 22: 191-217. [Medline]
2. Constant, P., F. Davodeau, M. A. Peyrat, Y. Poquet, G. Puzo, M. Bonneville, J. J. Fournié. 1994. Stimulation of human T cells by nonpeptidic mycobacterial ligands. Science 264: 267-270. [Abstract/Free Full Text]
3. Tanaka, Y., S. Sano, E. Nieves, G. De Libero, D. Rosa, R. L. Modlin, M. B. Brenner, B. R. Bloom, C. T. Morita. 1994. Nonpeptide ligands for human T cells. Proc. Natl. Acad. Sci. USA 91: 8175-8179. [Abstract/Free Full Text]
4. Tanaka, Y., C. T. Morita, E. Nieves, M. B. Brenner, B. R. Bloom. 1995. Natural and synthetic non-peptide antigens recognized by human T cells. Nature 375: 155-158. [Medline]
5. Belmant, C., E. Espinosa, F. Halary, I. Apostolou, E. Sicard, M. A. Payrat, A. Vercellone, P. Kourilsky, G. Gachelin, R. Poupot, et al 1999. 3-Formyl-1-butyl pyrophosphate: a novel mycobacterial metabolite-activating human T cells. J. Biol. Chem. 274: 32079-32084. [Abstract/Free Full Text]
6. Gober, H. J., M. Kistowska, L. Angman, P. Jeno, L. Mori, G. De Libero. 2003. Human T cell receptor cells recognize endogenous mevalonate metabolites in tumor cells. J. Exp. Med. 197: 163-168. [Abstract/Free Full Text]
7. Kunzmann, V., E. Bauer, M. Wilhelm. 1999. T-cell stimulation by pamidronate. N. Eng. J. Med. 340: 737-738. [Free Full Text]
8. Scotet, E., L. O. Martinez, E. Grant, R. Barbaras, P. Jeno, M. Guiraud, B. Monsarrat, X. Saulquin, S. Maillet, J. P. Esteve, et al 2005. Tumor recognition following V9V2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity 22: 71-80. [Medline]
9. Dieli, F., F. Poccia, M. Lipp, G. Sireci, N. Caccamo, C. Di Sano, A. Salerno. 2003. Differentiation of effector/memory V2 T cells and migratory routes in lymph nodes or inflammatory sites. J. Exp. Med. 198: 391-397. [Abstract/Free Full Text]
10. Bonneville, M., J. J. Fournié. 2005. Sensing cell stress and transformation through V9V2 T cell-mediated recognition of the isoprenoid pathway metabolites. Microbes Infect. 7: 503-509. [Medline]
11. Pao, W., L. Wen, A. L. Smith, A. Gulbranson-Judge, B. Zheng, G. Kelsoe, I. C. MacLennan, M. J. Owen, A. C. Hayday. 1996. T cell help of B cells is induced by repeated parasitic infection, in the absence of other T cells. Curr. Biol. 6: 1317-1325. [Medline]
12. Maloy, K. J., B. Odermatt, H. Hengartner, R. M. Zinkernagel. 1998. Interferon--producing T cell-dependent antibody isotype switching in the absence of germinal center formation during virus infection. Proc. Natl. Acad. Sci. USA 95: 1160-1165. [Abstract/Free Full Text]
13. Wen, L., S. J. Roberts, J. L. Viney, F. S. Wong, C. Mallick, R. C. Findly, Q. Peng, J. E. Craft, M. J. Owen, A. C. Hayday. 1994. Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in ⁺ T cells. Nature 369: 654-658. [Medline]
14. Peng, S. L., M. P. Madaio, D. P. Hughes, N. I. Crispe, M. J. Owen, L. Wen, A. C. Hayday, J. Craft. 1996. Murine lupus in the absence of T cells. J. Immunol. 156: 4041-4049. [Abstract]
15. Wen, L., W. Pao, F. S. Wong, Q. Peng, J. Craft, B. Zheng, G. Kelsoe, L. Dianda, M. J. Owen, A. C. Hayday. 1996. Germinal center formation, immunoglobulin class switching, and autoantibody production driven by "non " T cells. J. Exp. Med. 183: 2271-2282. [Abstract/Free Full Text]
16. Rajagopalan, S., T. Zordan, G. C. Tsokos, R. M. Lebovitz, M. W. Lieberman. 1990. Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4^–8^– T helper cell lines that express the T-cell antigen receptor. Proc. Natl. Acad. Sci. USA 87: 7020-7024. [Abstract/Free Full Text]
17. Horner, A. A., H. Jabara, N. Ramesh, R. S. Geha. 1995. T lymphocytes express CD40 ligand and induce isotype switching in B lymphocytes. J. Exp. Med. 181: 1239-1244. [Abstract/Free Full Text]
18. Brandes, M., K. Willimann, A. B. Lang, K. H. Nam, C. Jin, M. B. Brenner, C. T. Morita, B. Moser. 2003. Flexible migration program regulates T-cell involvement in humoral immunity. Blood 102: 3693-3701. [Abstract/Free Full Text]
19. Ruprecht, C. R., A. Lanzavecchia. 2006. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur. J. Immunol. 36: 810-816. [Medline]
20. Caccamo, N., S. Meraviglia, V. Ferlazzo, D. Angelini, G. Borsellino, F. Poccia, L. Battistini, F. Dieli, A. Salerno. 2005. Differential requirements for antigen or homeostatic cytokines for proliferation and differentiation of human V9V2 naive, memory and effector T cell subsets. Eur. J. Immunol. 35: 1764-1772. [Medline]
21. Schaerli, P., K. Willimann, A. B. Lang, M. Lipp, P. Loetscher, B. Moser. 2000. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J. Exp. Med. 192: 1553-1562. [Abstract/Free Full Text]
22. Breitfeld, D., L. Ohl, E. Kremmer, J. Ellwart, F. Sallusto, M. Lipp, R. Forster. 2000. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 192: 1545-1552. [Abstract/Free Full Text]
23. Glatzel, A., D. Wesch, F. Schiemann, E. Brandt, O. Janssen, D. Kabelitz. 2002. Patterns of chemokine receptor expression on peripheral blood T lymphocytes: strong expression of CCR5 is a selective feature of V2/V9 T cells. J. Immunol. 168: 4920-4929. [Abstract/Free Full Text]
24. Sallusto, F., D. Lenig, R. Forster, M. Lipp, A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712. [Medline]
25. Flynn, S., K. M. Toellner, C. Raykundalia, M. Goodall, P. Lane. 1998. CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J. Exp. Med. 188: 297-304. [Abstract/Free Full Text]
26. Walker, L. S. K., A. Gulbranson-Judge, S. Flynn, T. Brocker, C. Raykundalia, M. Goodall, R. Förster, M. Lipp, P. Lane. 1999. Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers. J. Exp. Med. 190: 1115-1122. [Abstract/Free Full Text]
27. Forster, R., G. Schweigard, S. Johann, T. Emrich, E. Kremmer, C. Nerl, M. Lipp. 1997. Abnormal expression of the B-cell homing chemokine receptor BLR1 during the progression of acquired immunodeficiency syndrome. Blood 90: 520-525. [Abstract/Free Full Text]
28. Vinuesa, C. G., S. G. Tangye, B. Moser, C. R. Mackay. 2005. Follicular B helper T cells in antibody responses and autoimmunity. Nat. Rev. Immunol. 5: 853-865. [Medline]
29. Wesch, D., A. Glatzel, D. Kabelitz. 2001. Differentiation of resting human peripheral blood T cells toward Th1- or Th2-phenotype. Cell Immunol. 12: 110-117.
30. Ordway, D. J., L. Pinto, L. Costa, M. Martins, C. Leandro, M. Viveiros, L. Amaral, M. J. Arroz, F. A. Ventura, H. M. Dockrell. 2005. T cell responses associated with the development of tuberculosis in health care workers. FEMS Immunol. Med. Microbiol. 43: 339-350. [Medline]
31. Ordway, D. J., L. Costa, M. Martins, H. Silveira, L. Amaral, M. J. Arroz, F. A. Ventura, H. M. Dockrell. 2004. Increased interleukin-4 production by CD8 and T cells in health-care workers is associated with the subsequent development of active tuberculosis. J. Infect. Dis. 190: 756-766. [Medline]
32. Sireci, G., E. Champagne, J. J. Fournie, F. Dieli, A. Salerno. 1997. Patterns of phosphoantigen stimulation of human V9/V2 T cell clones include Th0 cytokines. Hum. Immunol. 58: 70-82. [Medline]
33. Devilder, M. C., S. Maillet, I. Bouyge-Moreau, E. Donnadieu, M. Bonneville, E. Scotet. 2006. Potentiation of antigen-stimulated V9V2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation. J. Immunol. 176: 1386-1393. [Abstract/Free Full Text]
34. Hutloff, A., A. M. Dittrich, K. C. Beier, B. Eljaschewitsch, R. Kraft, I. Anagnostopoulos, R. A. Kroczek. 1999. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397: 263-266. [Medline]
35. Grewal, I. S., R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16: 111-135. [Medline]
36. Conti, L., R. Casetti, M. Cardone, B. Varano, A. Martino, F. Belardelli, F. Poccia, S. Gessani. 2005. Reciprocal activating interaction between dendritic cells and pamidronate-stimulated T cells: role of CD86 and inflammatory cytokines. J. Immunol. 174: 252-260. [Abstract/Free Full Text]
37. Ismaili, J., V. Olislagers, R. Poupot, J. J. Fournie, M. Goldman. 2002. Human T cells induce dendritic cell maturation. Clin. Immunol. 103: 296-302. [Medline]
38. Leslie, D. S., M. S. Vincent, F. M. Spada, H. Das, M. Sugita, C. T. Morita, M. B. Brenner. 2002. CD1-mediated / T cell maturation of dendritic cells. J. Exp. Med. 196: 1575-1584. [Abstract/Free Full Text]
39. Moser, B., M. Brandes. 2006. T cells: an alternative type of professional APC. Trends Immunol. 27: 112-118. [Medline]
40. Brandes, M., K. Willimann, B. Moser. 2005. Professional antigen-presentation function by human T cells. Science 309: 264-268. [Abstract/Free Full Text]

This article has been cited by other articles:

				M. Brandes, K. Willimann, G. Bioley, N. Levy, M. Eberl, M. Luo, R. Tampe, F. Levy, P. Romero, and B. Moser Cross-presenting human {gamma}{delta} T cells induce robust CD8+ {alpha}{beta} T cell responses PNAS, February 17, 2009; 106(7): 2307 - 2312. [Abstract] [Full Text] [PDF]

				D. Vermijlen, P. Ellis, C. Langford, A. Klein, R. Engel, K. Willimann, H. Jomaa, A. C. Hayday, and M. Eberl Distinct Cytokine-Driven Responses of Activated Blood {gamma}{delta} T Cells: Insights into Unconventional T Cell Pleiotropy J. Immunol., April 1, 2007; 178(7): 4304 - 4314. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Caccamo, N. Articles by Salerno, A. Search for Related Content PubMed PubMed Citation Articles by Caccamo, N. Articles by Salerno, A.